Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells

作者: F. Okada , J. W. Rak , B. S. Croix , B. Lieubeau , M. Kaya

DOI: 10.1073/PNAS.95.7.3609

关键词: AngiogenesisTransfectionCancer researchImmunologyBiologyVascular endothelial growth factor CCell cultureVascular endothelial growth factor AOncogeneVascular endothelial growth factorPopulation

摘要: Targeted disruption of the single mutant K-ras allele in two human colorectal carcinoma cell lines (DLD-1 and HCT-116) leads to loss tumorigenic competence nude mice with retention ability grow indefinitely monolayer culture. Because expression oncogene these is associated marked up-regulation vascular endothelial growth factor/vascular permeability factor (VEGF/VPF), we sought determine whether this potent angiogenesis inducer plays a role K-ras-dependent competence. Transfection VEGF121 antisense vector into DLD-1 HCT-116 cells resulted suppression VEGF/VPF production by 3- 4-fold. The VEGF/VPF-deficient sublines, unlike parental population or controls, were profoundly suppressed their form tumors for as long 6 months after injection. In contrast, vitro sublines was unaffected, thus demonstrating critical importance an angiogenic cells. full-length cDNA nontumorigenic knockout weak but detectable restoration vivo subset transfectants, no consistent change properties vitro. findings indicate that ras-oncogene-dependent necessary, not sufficient, progressive tumor highlight relative contribution oncogenes, such K-ras, process angiogenesis.

参考文章(36)
M. Detmar, A. M. Dvorak, L. F. Brown, H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology. ,vol. 146, pp. 1029- 1039 ,(1995)
J. Filmus, Wen Shi, M. J. Wong, L. L. Colombo, C. J. Conti, A. I. Robles, Induction of cyclin D1 overexpression by activated ras. Oncogene. ,vol. 9, pp. 3627- 3633 ,(1994)
Noël Bouck, Veronica Stellmach, Stephanie C. Hsu, How Tumors Become Angiogenic Advances in Cancer Research. ,vol. 69, pp. 135- 174 ,(1996) , 10.1016/S0065-230X(08)60862-3
Steven A. Stacker, Mary Saleh, Andrew F. Wilks, Inhibition of Growth of C6 Glioma Cells in Vivo by Expression of Antisense Vascular Endothelial Growth Factor Sequence Cancer Research. ,vol. 56, pp. 393- 401 ,(1996)
Brian Fendly, Mien Chie Hung, Robert S. Kerbel, Alicia M. Viloria Petit, Patricia Rockwell, Neil Goldstein, Janusz Rak, Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. American Journal of Pathology. ,vol. 151, pp. 1523- 1530 ,(1997)
Amato J. Giaccia, Keith R. Laderoute, Eunice Y. Chen, Nathalie M. Mazure, Patricia Yeh, Oncogenic Transformation and Hypoxia Synergistically Act to Modulate Vascular Endothelial Growth Factor Expression Cancer Research. ,vol. 56, pp. 3436- 3440 ,(1996)
Nancy E. Kohl, Charles A. Omer, Michael W. Conner, Neville J. Anthony, Joseph P. Davide, S. Jane Desolms, Elizabeth A. Giuliani, Robert P. Gomez, Samuel L. Graham, Kelly Hamilton, Laurence K. Handt, George D. Hartman, Kenneth S. Koblan, Astrid M. Kral, Patricia J. Miller, Scott D. Mosser, Timothy J. O'Neill, Elaine Rands, Michael D. Schaber, Jackson B. Gibbs, Allen Oliff, Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice Nature Medicine. ,vol. 1, pp. 792- 797 ,(1995) , 10.1038/NM0895-792
Ronald N. Buick, Jorge Filmus, Andrea Quaroni, Activated H-ras transforms rat intestinal epithelial cells with expression of α-TGF☆ Experimental Cell Research. ,vol. 170, pp. 300- 309 ,(1987) , 10.1016/0014-4827(87)90308-9